Merge pull request #23 from smvgarcia/update-genderID

fix another typo

docs/human-subject-applicability.md

@@ -54,7 +54,7 @@
     > If your study has **clear special applicability** to humans of a specific gender identity or identities, <u>mark all that apply</u>
 
     > Examples of studies with **clear special applicability**:
-    >> * a basic science study using biochemistry experiments to investigate potential molecular interactions between puberty-blocking drugs and opioid receptor pathways, and using animal model experiments to investigate the impact of co-administration of puberty-blocking drugs and opioids in an adolescent mouse injury pain model on opioid-induced pain-relief and on risk of opioid addiction &rarr; **this study may choose 'Transgender man/trans man/female-to-male (FTM)', ‘Transgender woman/trans woman/male-to-female (MTF)’, and 'Genderqueer/gender nonconforming/neither exclusively male nor femaler'** (puberty blockers can be prescribed to early-adolescents who consider their gender identity to be trans OR non-binary; non-binary would be covered under the Genderqueer category)    
+    >> * a basic science study using biochemistry experiments to investigate potential molecular interactions between puberty-blocking drugs and opioid receptor pathways, and using animal model experiments to investigate the impact of co-administration of puberty-blocking drugs and opioids in an adolescent mouse injury pain model on opioid-induced pain-relief and on risk of opioid addiction &rarr; **this study may choose 'Transgender man/trans man/female-to-male (FTM)', ‘Transgender woman/trans woman/male-to-female (MTF)’, and 'Genderqueer/gender nonconforming/neither exclusively male nor female'** (puberty blockers can be prescribed to early-adolescents who consider their gender identity to be trans OR non-binary; non-binary would be covered under the Genderqueer category)    
     * a clinical trial investigating the efficacy of adding a physical therapy and swim exercise therapy regimen to short-course opioids to prevent transition of acute post-surgical pain to chronic pain in cisgender women and transgender men following surgical mastectomy &rarr; **this study may choose 'Female' and 'Transgender man/trans man/female-to-male (FTM)**